Earnings Insights
AI-generated analysis of quarterly earnings, concall highlights, and financial performance across Indian listed companies.
How to use these insights
Each article is built from earnings call transcripts and structured rank signals. Start with the latest summary, then open the stock page for the full company view, the concall page for quarter-by-quarter commentary, and the rankings dashboard to compare peers.
Blue Dart Expres Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
Surface B2B has shown strong growth (~14%) and is contributing to overall volume increase. Key concall takeaways from Blue Dart Expres's Q1 FY27 earnings call…
25 Aug 2026
Zydus Wellness Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
EBITDA percentage expanded by 0.4% on a like-to-like basis; net profit (excluding amortization) grew 26.5% YoY in Q1 FY27. Key concall takeaways from Zydus…
25 Aug 2026
Emami Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
Domestic core business grew ~6% in Q1 FY27; hair care at 11%, skin care at 3% (Rajesh Sharma, pg 13). Key concall takeaways from Emami's Q1 FY27 earnings call…
25 Aug 2026
Torrent Pharma. Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
Organic India growth excluding semaglutide showed a 15-16% trajectory; top 10 base brands are growing over 20%. Key concall takeaways from Torrent Pharma.'s Q1…
25 Aug 2026
ASK Automotive Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
70 crore to Rs. Key concall takeaways from ASK Automotive's Q1 FY27 earnings call — and how it ranks against sector peers.
25 Aug 2026
Shilpa Medicare Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
Formulations have over 50% captive production, supporting stable growth. Key concall takeaways from Shilpa Medicare's Q1 FY27 earnings call — and how it ranks…
25 Aug 2026
Kirl. Brothers Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
217 crores. Key concall takeaways from Kirl. Brothers's Q1 FY27 earnings call — and how it ranks against sector peers.
25 Aug 2026
Cohance Life Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
The commercial OTIF (On-Time In-Full) rate remains near 100%, indicating strong order fulfillment performance. Key concall takeaways from Cohance Life's Q1…
25 Aug 2026
Kansai Nerolac Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
Moderate capacity utilization currently; capex intended to meet demand growth and improve ROCE toward 18%. Key concall takeaways from Kansai Nerolac's Q1 FY27…
25 Aug 2026
Garware Hi Tech Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
Garware Hi-Tech Films is confident of achieving INR 2,500 crores+ revenue in the current year (FY27). Key concall takeaways from Garware Hi Tech's Q1 FY27…
25 Aug 2026
Sarda Energy Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
INR 300 crores in a waste heat recovery power plant at Vizag to improve energy efficiency and resource utilization. Key concall takeaways from Sarda Energy's…
25 Aug 2026
Sundram Fasten. Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
Profit grew nearly 10% YoY, aided by control over fixed costs despite input inflation. Key concall takeaways from Sundram Fasten.'s Q1 FY27 earnings call — and…
25 Aug 2026
Deepak Nitrite Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
Strong start to FY27 with record quarterly revenue of INR 2,592 crore, a 35% YoY and 22% QoQ growth. Key concall takeaways from Deepak Nitrite's Q1 FY27…
25 Aug 2026
Garden Reach Sh. Q1 FY27: Order Book ₹13,596.26 Cr | Arthneeti
Q1 FY27
Current total order book: ₹13,596.26 crore . Key concall takeaways from Garden Reach Sh.'s Q1 FY27 earnings call — and how it ranks against sector peers.
25 Aug 2026
Krishna Institu. Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
Current FY '27 CAPEX is around INR 100-125 crore over the next nine months, mostly tied to Rajahmundry hospital (INR 60-75 crore) and minor additional spend in…
25 Aug 2026
Narayana Hrudaya Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
Clinics contribute significantly, with OP consults growing about 30% YoY and 66,000 consultations in Q1, supporting hospital footfalls and overall revenue. Key…
25 Aug 2026
Navin Fluo.Intl. Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
Contractual discussions ongoing for long-term supply agreements (e.g., 35-45% of R32 capacity contracted). Key concall takeaways from Navin Fluo.Intl.'s Q1…
25 Aug 2026
KEI Industries Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
Although market demand and capacity allow for higher growth (up to ~30%), management prefers sustainable growth over aggressive expansion. Key concall…
25 Aug 2026
Jindal Stain. Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
Capex of INR 2,400-2,600 crores planned in FY27 primarily for downstream expansion. Key concall takeaways from Jindal Stain.'s Q1 FY27 earnings call — and how…
25 Aug 2026
Uno Minda Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
The alloy wheel business is growing, with INR566 crores revenue in four-wheelers and INR284 crores in two-wheelers reported in the latest quarter. Key concall…
25 Aug 2026